In addition, the low expression or loss of FOXA1 in basal tumors was described in the development of squamous cell carcinoma in preclinical models of bladder cancer, which is in concordance with the subtype association in the current study [29]. This evidence concerns the gene FOXA1 and urinary bladder carcinoma.